Patent applications and USPTO patent grants for Ye; Zhixiong.The latest application filed is for "compounds for treating or inhibiting recurrence of acute myeloid leukemia".
Patent | Date |
---|---|
Inhibitors of cellular metabolic processes Grant 11,325,914 - Konteatis , et al. May 10, 2 | 2022-05-10 |
Compounds For Treating Or Inhibiting Recurrence Of Acute Myeloid Leukemia App 20210299128 - Serrano-Wu; Michael ;   et al. | 2021-09-30 |
Inhibitors of cellular metabolic processes Grant 10,800,782 - Konteatis , et al. October 13, 2 | 2020-10-13 |
Inhibitors Of Cellular Metabolic Processes App 20190233424 - Konteatis; Zenon D. ;   et al. | 2019-08-01 |
Inhibitors of cellular metabolic processes Grant 10,329,298 - Konteatis , et al. | 2019-06-25 |
Compounds and their methods of use Grant 10,000,479 - Cianchetta , et al. June 19, 2 | 2018-06-19 |
Inhibitors Of Cellular Metabolic Processes App 20180079753 - Konteatis; Zenon D. ;   et al. | 2018-03-22 |
Therapeutically active compositions and their methods of use Grant 9,856,279 - Cao , et al. January 2, 2 | 2018-01-02 |
Therapeutically Active Compositions And Their Methods Of Use App 20170210749 - Cao; Sheldon ;   et al. | 2017-07-27 |
Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer Grant 9,662,327 - Cao , et al. May 30, 2 | 2017-05-30 |
Compounds And Their Methods Of Use App 20170137414 - Cianchetta; Giovanni ;   et al. | 2017-05-18 |
Therapeutically Active Compositions And Their Methods Of Use App 20160229876 - Cao; Sheldon ;   et al. | 2016-08-11 |
Therapeutic compounds and compositions Grant 9,365,545 - Cianchetta , et al. June 14, 2 | 2016-06-14 |
Therapeutic Compounds And Compositions App 20160046579 - Cianchetta; Giovanni ;   et al. | 2016-02-18 |
Therapeutic Compounds And Compositions App 20150336931 - Cianchetta; Giovanni ;   et al. | 2015-11-26 |
Therapeutic compounds and compositions Grant 9,108,921 - Cianchetta , et al. August 18, 2 | 2015-08-18 |
Therapeutic Compounds And Compositions App 20140288081 - Cianchetta; Giovanni ;   et al. | 2014-09-25 |
Therapeutically Active Compositions And Their Methods Of Use App 20140213580 - Cao; Sheldon ;   et al. | 2014-07-31 |
Therapeutically Active Compositions And Their Methods Of Use App 20140206673 - Cao; Sheldon ;   et al. | 2014-07-24 |
Triazole Beta Carboline Derivatives As Anti-diabetic Agents App 20110201615 - Guo; Liangqin ;   et al. | 2011-08-18 |
Beta Carboline Derivatives As Antidiabetic Compounds App 20100184758 - Dobbelaar; Peter H. ;   et al. | 2010-07-22 |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators Grant 7,652,024 - Bakshi , et al. January 26, 2 | 2010-01-26 |
Acylated Spiropiperidine Derivatives As Melanocortin-4 Receptor Modulators App 20090325990 - Bakshi; Raman K. ;   et al. | 2009-12-31 |
Acylated piperidine derivatives as melanocortin-4 receptor modulators App 20090253744 - Bakshi; Raman K. ;   et al. | 2009-10-08 |
Piperazine urea derivatives as melanocortin-4 receptor agonists Grant 7,414,057 - Bakshi , et al. August 19, 2 | 2008-08-19 |
Acylated Piperidine Derivatives as Melanocortin 4-Receptor Agonists App 20080051430 - Barakat; Khaled J. ;   et al. | 2008-02-28 |
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists Grant 7,329,673 - Guo , et al. February 12, 2 | 2008-02-12 |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists Grant 7,276,520 - Nargund , et al. October 2, 2 | 2007-10-02 |
Acylated piperazine derivatives as melanocortin-4 receptor agonists Grant 7,160,886 - Bakshi , et al. January 9, 2 | 2007-01-09 |
Bridged piperidine derivatives as melanocortin receptor agonists Grant 7,115,628 - Ye , et al. October 3, 2 | 2006-10-03 |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists App 20060194780 - Nargund; Ravi P. ;   et al. | 2006-08-31 |
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists App 20060183904 - Guo; Liangqin ;   et al. | 2006-08-17 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists Grant 7,015,235 - Goulet , et al. March 21, 2 | 2006-03-21 |
Piperazine urea derivatives as melanocortin-4 receptor agonists App 20060040906 - Bakshi; Raman Kumar ;   et al. | 2006-02-23 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20060035935 - Goulet; Mark T. ;   et al. | 2006-02-16 |
Acylated piperazine derivatives as melanocortin-4 receptor agonists App 20040204398 - Bakshi, Raman K. ;   et al. | 2004-10-14 |
Bridged piperidine derivatives as melanocortin receptor agonists App 20040180923 - Ye, Zhixiong ;   et al. | 2004-09-16 |
Substituted piperidines as melanocortin receptor agonists Grant 6,767,915 - Bakshi , et al. July 27, 2 | 2004-07-27 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20040097546 - Goulet, Mark T. ;   et al. | 2004-05-20 |
Substituted Piperidines As Melanocortin Receptor Agonists App 20030236262 - Bakshi, Raman K ;   et al. | 2003-12-25 |
Substituted piperidines as melanocortin-4 receptor agonists App 20020137664 - Bakshi, Raman K. ;   et al. | 2002-09-26 |
Spiropiperidine derivatives as melanocortin receptor agonists Grant 6,410,548 - Nargund , et al. June 25, 2 | 2002-06-25 |
Melanocortin receptor agonists Grant 6,376,509 - Bakshi , et al. April 23, 2 | 2002-04-23 |
Substituted piperidines as melanocortin-4 receptor agonists Grant 6,350,760 - Bakshi , et al. February 26, 2 | 2002-02-26 |
Substituted piperidines as melanocortin receptor agonists App 20020019523 - Palucki, Brenda L. ;   et al. | 2002-02-14 |
Melanocortin receptor agonists App 20020004512 - Bakshi, Raman Kumar ;   et al. | 2002-01-10 |
Spiropiperidine derivatives as melanocortin receptor agonists App 20010029259 - Nargund, Ravi P. ;   et al. | 2001-10-11 |
Spiropiperidine derivatives as melanocortin receptor agonists Grant 6,294,534 - Nargund , et al. September 25, 2 | 2001-09-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.